NCT06317662 · Interventional trial
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Overall registry status Recruiting
Phase 2
Conditions Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia
Delaware Valley sites
- Children's Hospital of Philadelphia · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory